Table 1 Patient demographics and medical information
Patient | Sex | Age | Weight (kg) | Co- infection | Symptom | Started with vaccination program* | Suppl. oxygen | Medication$ | Antibiotics | Other§ |
|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 2 months¥ | 4.7 | – | Dyspnea | No | Yes | Ipratropium (0.25 mg) Salbutamol (2.5 mg) Xylometazoline (0.25 mg/ml) Paracetamol (60 mg) | No | No |
2 | F | 1 month | 5.0 | – | Bronchiolitis | No | Yes | Xylometazoline (0.25 mg/ml) Paracetamol (60 mg) | No | Vitamin K oil droplets |
3 | M | 10 days | 3.8 | – | Sinusitis | No | Yes | Xylometazoline (0.25 mg/ml) Paracetamol (60 mg) | Amoxicillin (500 mg/ml) Cefotaxime (500 mg/ml) | No |
4 | M | 2 months | 6.4 | RV | Dyspnea | No | Yes | Xylometazoline (0.25 mg/ml) Paracetamol (120 mg) | No | Vitamin K oil droplets Cholecalciferol (10 µg) |
5 | M | 7 months | 11.1 | RV | Bronchiolitis & Tachypnea | Yes | Yes | Xylometazoline (0.25 mg/ml) Paracetamol (240 mg) Hypertonic saline inhalation (2.5 mg/ml) | No | Cholecalciferol (10 µg) |
6 | F | 3 months | 6.0 | – | Bronchiolitis & Dyspnea | Yes | Yes | Ibuprofen (20 mg/ml) Paracetamol (120 mg) Hypertonic saline inhalation (0.9 mg/ml) | No | Cholecalciferol (10 µg) |